Similar Papers

Paper Title
Journal
Date
Author
Adjuvant chemotherapy for surgically resected non–small cell lung cancer
Stephanie Heon ... Bruce E Johnson
The Journal of Thoracic and Cardiovascular Surgery | VOL. 144
Stephanie Heon, et. al.Stephanie Heon ... Bruce E Johnson
12 Apr 2012
Chemotherapy + PD-1/PD-L1 Blockade Should Be the Preferred Option in the Neoadjuvant Therapy of NSCLC
Samuel Rosner ... Patrick M Forde
Journal of Thoracic Oncology | VOL. 17
Samuel Rosner, et. al.Samuel Rosner ... Patrick M Forde
17 Mar 2022
Thoracoscopic Lobectomy Is Associated With Superior Compliance With Adjuvant Chemotherapy in Lung Cancer
Jin Gu Lee ... Kyung Young Chung
The Annals of Thoracic Surgery | VOL. 91
Jin Gu Lee, et. al.Jin Gu Lee ... Kyung Young Chung
20 Jan 2011
P2.03a-068 Impact of Platinum/Pemetrexed versus Other Platinum-Based Regimens on Adjuvant Chemotherapy in Resected Adenocarcinoma Lung Cancer: Topic: Clinical Trials
Xiaoyu Zhai ... Junling Li
Journal of Thoracic Oncology | VOL. 12
Xiaoyu Zhai, et. al.Xiaoyu Zhai ... Junling Li
31 Dec 2016
View more papers

More From: Lung Cancer

Paper Title
Journal
Date
Author
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies
Hiroaki Akamatsu ... Tetsuya Mitsudomi
Lung Cancer | VOL. -
Hiroaki Akamatsu, et. al.Hiroaki Akamatsu ... Tetsuya Mitsudomi
01 Feb 2025
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer
Joaquim Bosch-Barrera ... Teresa Morán
Lung Cancer | VOL. -
Joaquim Bosch-Barrera, et. al.Joaquim Bosch-Barrera ... Teresa Morán
01 Feb 2025
Exercise medicine for individuals diagnosed with Lung Cancer: A systematic review and meta-analysis of health outcomes
Salvatore Ficarra ... Christina M Dieli-Conwright
Lung Cancer | VOL. -
Salvatore Ficarra, et. al.Salvatore Ficarra ... Christina M Dieli-Conwright
01 Feb 2025
Evaluating the safety of antibody-drug conjugates in lung cancer: A systematic review and meta-analysis
Qi He ... Mengzhao Wang
Lung Cancer | VOL. -
Qi He, et. al.Qi He ... Mengzhao Wang
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.